Zhejiang Huakang Pharmaceutical Co Ltd (605077) — Cash Flow Quality Index
Zhejiang Huakang Pharmaceutical Co Ltd (605077) has a Cash Flow Quality Index of 0.55x as of December 2024. Operating cash flow of CN¥146.50 Million is below net income of CN¥268.48 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Zhejiang Huakang Pharmaceutical Co Ltd (605077) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Huakang Pharmaceutical Co Ltd Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Zhejiang Huakang Pharmaceutical Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Zhejiang Huakang Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Zhejiang Huakang Pharmaceutical Co Ltd (2016–2024)
Year-by-year earnings quality comparison for Zhejiang Huakang Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Zhejiang Huakang Pharmaceutical Co Ltd market cap and net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.55x | CN¥146.50 Million | CN¥268.48 Million | ▼ -67.3% |
| 2023 | 1.67x | CN¥619.47 Million | CN¥371.45 Million | ▲ +95.8% |
| 2022 | 0.85x | CN¥271.98 Million | CN¥319.28 Million | ▼ -23.7% |
| 2021 | 1.12x | CN¥264.32 Million | CN¥236.71 Million | ▲ +2.3% |
| 2020 | 1.09x | CN¥335.24 Million | CN¥307.17 Million | ▲ +4.8% |
| 2019 | 1.04x | CN¥281.31 Million | CN¥270.11 Million | ▲ +47.3% |
| 2018 | 0.71x | CN¥140.97 Million | CN¥199.38 Million | ▼ -50.9% |
| 2017 | 1.44x | CN¥80.56 Million | CN¥55.94 Million | ▼ -55.5% |
| 2016 | 3.24x | CN¥93.02 Million | CN¥28.71 Million | — |